1. The feature selection approach for evaluation of potential rheumatoid arthritis markers using MALDI-TOF datasets
   Bartosz Urbaniak et al, 2017, Analytical Biochemistry CrossRef
2. Serum complements and immunoglobulin profiles in systemic lupus erythematosus patients: An observational study at a teaching hospital
   Bitan Naik et al, 2022, Journal of Family Medicine and Primary Care CrossRef
3. Regulatory T Cells and Their Association with Serum Markers and Symptoms in Systemic Lupus Erythematosus and Rheumatoid Arthritis
   Vikas Kailashiya et al, 2019, Immunological Investigations CrossRef
4. Possible roles of anti-type II collagen antibody and innate immunity in the development and progression of diabetic retinopathy
   Tsunehiko Ikeda et al, 2022, Graefe's Archive for Clinical and Experimental Ophthalmology CrossRef
5. CRP Serum Levels Are Associated with High Cardiometabolic Risk and Clinical Disease Activity in Systemic Lupus Erythematosus Patients
   Karen Pesqueda-Cendejas et al, 2022, Journal of Clinical Medicine CrossRef
6. Elevated levels of inflammatory markers in women with rheumatoid arthritis
   Camila Medeiros Costa et al, 2019, Journal of Immunoassay and Immunochemistry CrossRef
7. Alpha-hydroxybutyrate dehydrogenase as a biomarker for predicting systemic lupus erythematosus with liver injury
   Haitao Yu et al, 2019, International Immunopharmacology CrossRef
8. CLINICAL PROFILE AND INCIDENCE OF INFECTION IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AT MEDICAL INPATIENT INSTALLATION, DEPARTMENT OF INTERNAL MEDICINE, DR. SOETOMO GENERAL ACADEMIC HOSPITAL, SURABAYA, INDONESIA IN 2016
   Desy Trilistyoati et al, 2021, Majalah Biomorfologi CrossRef
9. Risk Factors for Poor Prognosis of Severe Infection in Children With Idiopathic Nephrotic Syndrome: A Double-Center, Retrospective Study
   Hengci Zhang et al, 2021, Frontiers in Pediatrics CrossRef
10. Serum Homocysteine Concentration Is Significantly Associated with Inflammatory/Immune Factors
    Tianyu Li et al, 2015, PLOS ONE CrossRef
11. The Association of Complements, TGF-β, and IL-6 with Disease Activity, Renal Damage, and Hematological Activity in Patients with Naïve SLE
    Yuliasih Yuliasih et al, 2022, International Journal of Inflammation CrossRef
12. Inflammatory markers in systemic lupus erythematosus
    Martin Aringer, 2020, Journal of Autoimmunity CrossRef
13. Changes of Serum IL-6, IL-17, and Complements in Systemic Lupus Erythematosus Patients
    Yamei Tang et al, 2019, Journal of Interferon & Cytokine Research CrossRef
14. HLA-DRB1*04 as a Risk Allele to Systemic Lupus Erythematosus and Lupus Nephritis in the Malay Population of Malaysia
    Malarvili Selvaraja et al, 2021, Frontiers in Medicine CrossRef
15. Coagulation cascade and complement system in systemic lupus erythematosus
    Yan Liang et al, 2018, Oncotarget CrossRef
16. Evaluation of potential biomarkers for the diagnosis and monitoring of Systemic Lupus Erythematosus using the Cytometric Beads Array (CBA)
    L.C.V. Alves et al, 2019, Clinica Chimica Acta CrossRef
17. A glimpse into the future of systemic lupus erythematosus
    Martin Aringer et al, 2022, Therapeutic Advances in Musculoskeletal Disease CrossRef
18. Differentiation between thyroid‐associated orbitopathy and Graves’ disease by iTRAQ‐based quantitative proteomic analysis
    Jianshu Kang et al, 2021, FEBS Open Bio CrossRef
19. Effects and mechanisms of vitamin A and vitamin E on the levels of serum leptin and other related cytokines in rats with rheumatoid arthritis
    RI-BO XIONG et al, 2014, Experimental and Therapeutic Medicine CrossRef
20. Transcriptomic features of systemic lupus erythematosus patients in flare and changes during acute in-hospital treatment
    Zhongyi Liu et al, 2023, Rheumatology CrossRef
21. Overview on the role of complement-specific autoantibodies in diseases
    Alexandra Tünde Matola et al, 2022, Molecular Immunology CrossRef